Furthermore, some of these proteins act as tumour suppressors, by proapoptotic and increasing cell survival (e.g., FASTKD3) [9] while othersact as pro-oncogenes and poor prognostic factors (FASTK, FASTKD2, FASTKD4) [25,27,28,34]. The gene discussed is FASTK; the disease is neoplasm.